| Old Articles: <Older 2141-2150 Newer> |
|---|
 |
Chemistry World
October 9, 2013 |
Solvay expands surfactants business with Chemlogics buyout Speciality chemicals group Solvay has agreed to buy Chemlogics -- a US firm specializing in chemicals for oil and gas exploration -- for $1.3 billion ( 840 million) in cash.   |
National Defense
November 2013
Valerie Insinna |
Vehicle System Would Alert Drivers to Potential Repair Needs The Michigan based Tweddle Group, debuted its connected intelligent vehicle management system at the Defence Security and Equipment International exhibition in London this September. |
Chemistry World
October 4, 2013
Phillip Broadwith |
Lundbeck cuts jobs in Europe, but expands in US Danish drugmaker Lundbeck is cutting 180-200 jobs in Europe as part of its ongoing restructuring program. However, the company is currently in the process of expanding its staff in the US. |
Chemistry World
October 2, 2013
Phillip Broadwith |
Aspen acquires anticoagulant brands South African generics manufacturer Aspen has bought two heparin-derived thrombosis drugs from GlaxoSmithKline. |
Chemistry World
September 30, 2013
Phillip Broadwith |
Clariant expands into China Speciality chemicals major Clariant is expanding its activities in China. The company has acquired the organic pigments business of Jiangsu Multicolor Fine Chemical, and plans to build a new pigments plant in Jiangsu province. |
Chemistry World
September 25, 2013
Phillip Broadwith |
New respiratory drugs neck and neck A flurry of regulatory approvals has seen three new drugs approved for asthma and chronic obstructive pulmonary disease in the European and Japanese markets. |
AskMen.com
September 19, 2013
Simon Kuper |
The Real Effect Of Major Sporting Events On Host Cities Since the 1990s many academic economists have researched the effects of hosting these tournaments, and they pretty much agree: Hosting doesn't make you rich. |
Pharmaceutical Executive
September 1, 2013
William Looney |
High Noon For Hot Markets Fading growth, overstretched governments, and a global governance backlash against pharma business are turning up the heat on the performance of emerging country markets. |
Pharmaceutical Executive
September 1, 2013 |
T-TIPing the Balance in Industry's Favor By the start of 2014, industry expects to have a clearer idea of how far the US-EU free trade pact is going. |
Commercial Investment Real Estate
Sep/Oct 2013
Rich Rosfelder |
Cross-Border Migration What's driving inbound investment? As the immigration debate raged in Washington, D.C., inbound international investors were quietly establishing themselves as big players in the Federal City's commercial real estate market. |
| <Older 2141-2150 Newer> Return to current articles. |
